Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Rocket Pharmaceuticals (RCKT)  
$23.09 0.37 (1.63%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 92,610,000
Market Cap: 2.14(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $15.07 - $31.94
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Rocket Pharmaceuticals is a clinical-stage, multi-platform biotechnology company focused on the development of gene therapies for rare and devastating pediatric diseases. Co. has three clinical-stage ex vivo lentiviral vector. These include programs for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction, and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,355,932
Total Buy Value $0 $0 $0 $19,999,997
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 418,173 438,811 467,219 487,632
Total Sell Value $11,574,225 $12,042,227 $12,602,151 $12,990,263
Total People Sold 7 7 7 8
Total Sell Transactions 12 14 24 29
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 66
  Page 3 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Militello John See Remarks   •       •      –    2023-02-17 4/A S $19.06 $20,509 D/D (1,076) 1,782     -
   Militello John See Remarks   •       •      –    2023-02-17 4 S $19.06 $23,711 D/D (1,244) 1,614 -3%     
   Shah Gaurav CEO   •       •      –    2023-02-17 4 S $19.06 $232,418 D/D (12,194) 536,885 -3%     
   Schwartz Jonathan David See Remarks   •       •      –    2023-02-17 4 S $19.06 $67,796 D/D (3,557) 94,546 -3%     
   Militello John See Remarks   •       •      –    2023-02-14 4 A $0.00 $0 D/D 11,067 57,729     -
   Militello John See Remarks   •       •      –    2023-02-14 4/A OE $0.00 $0 D/D 2,858 2,858     -
   Schwartz Jonathan David See Remarks   •       •      –    2023-02-14 4/A OE $0.00 $0 D/D 8,574 98,103     -
   Shah Gaurav CEO   •       •      –    2023-02-14 4/A OE $0.00 $0 D/D 31,440 549,079     -
   Patel Kinnari See Remarks   •       •      –    2023-02-14 4/A OE $0.00 $0 D/D 15,720 166,566     -
   Wong Roderick Director   –       •       •   2022-12-01 4 A $0.00 $0 I/I 529,038 18,157,605     -
   Wong Roderick Director   –       •       •   2022-10-06 4 B $14.75 $19,999,997 I/I 1,355,932 17,628,567 2.25 8%     
   Militello John See Remarks   •       •      –    2022-08-12 4 A $0.00 $0 D/D 14,310 46,662     -
   Militello John See Remarks   •       •      –    2022-04-18 4 A $0.00 $0 D/D 7,932 32,352     -
   Schwartz Jonathan David See Remarks   •       •      –    2022-04-01 4/A AS $15.86 $724,589 D/D (45,000) 89,529     -
   Schwartz Jonathan David See Remarks   •       •      –    2022-03-31 4/A AS $15.90 $724,500 D/D (45,000) 134,529     -
   Schwartz Jonathan David See Remarks   •       •      –    2022-03-30 4 AS $15.94 $738,652 D/D (45,000) 179,529 2%     
  66 Records found
  1  2  3    
  Page 3 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us